Clinical Trial Update: Effect of Rasagiline on Balance in Parkinson's Disease as Measured by Computerized Posturography [Phase 4]

View source ↗

Summary

The Phase 4 clinical trial evaluating rasagiline on balance in Parkinson's disease has been withdrawn; no results are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Azilect (rasagiline)

Snippet

Sponsor: New York Medical College | Conditions: PARKINSON DISEASE (Disorder) | Phase 4 | Status: WITHDRAWN